Skip to main contentSkip to navigationSkip to search

First Quarter 2023 Highlights

”In the first quarter, we made headway on our 2023 priorities. We invested significant capital to accrete ownership in Spring Health and Agreena and financed these investments by exiting our remaining shareholding in Teladoc – ending the quarter with a net cash position remaining above SEK 10bn. The market backdrop continued to be volatile, exacerbated by distress in the banking sector, impacting the financial ecosystem our growth companies form part of. The impact on Kinnevik and our investees was limited, but the events serve as an important reminder of the fragility of current markets and the importance of financial resilience in these uncertain times.”

Georgi Ganev, CEO of Kinnevik

Kinnevik in numbers


Sek, Net asset value


Nav per share


Change in nav Q/Q


1 year TSR


5 year TSR

Conference Call 10am CEST

Welcome to listed to the conference call presenting the first quarter results 2023.

Link to webcast

(listen only)

Those who wish to ask questions during the conference call are welcome to register via the below link. Participants will receive dial-in numbers and confirmation code upon registration. Please make sure to register and dial in a few minutes before the call begins.

Link to conference call

(for participants)